Drug Profile
Research programme: PCSK9 protein inhibitors - Genentech
Alternative Names: EGF66 Fc; Pep2 8Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Genentech
- Class Immunoglobulin fusion proteins; Peptides; Peptidomimetics; Proteins
- Mechanism of Action PCSK9 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Hypercholesterolaemia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Hypercholesterolaemia in USA (Parenteral, Injection)